Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-7

Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1,irRC,and iRECIST criteria: comparison with subjective assessment

Ying-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen [...]

Acta Radiologica

Open access

Research article

First published 2023

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

Li-Na He, Tao Chen, Sha Fu [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021-3

Feasibility of quantitative and volumetric enhancement measurement to assess tumor response in patients with breast cancer after early neoadjuvant chemotherapy

Jie Ding, Hongyan Xiao, Weiwei Deng [...]

Journal of International Medical Research

Open access

Review article

First published 2026-2

iRECIST: A Case Based Users Guide for Radiologists

Conor Waters, Darragh Halpenny

Canadian Association of Radiologists Journal

Retricted access

Research article

First published 2017-06

Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety,Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival

Nathaniel C. Swinburne, Derek M. Biederman, Cecilia Besa [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2025-11

Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?

Carmine Picone, Annamaria Porto, Roberta Fusco [...]

Cancer Control

Retricted access

Research article

First published 2019-7

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib

Iben R Andersen, Rene Olesen, Anders K Boysen [...]

Acta Radiologica

Retricted access

Research article

First published 2022-10

Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized,Phase 2,Open-Label Multicenter Trial

Naifa L. Busaidy, Bhavana Konda, Lai Wei [...]

Thyroid®

Retricted access

Review article

First published 2018-3

The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST

Alessandro Inno, Giuseppe Lo Russo, Matteo Salgarello [...]

Tumori Journal

Open access

Research article

First published 2022

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC

Filippo G. Dall’Olio, Claudia Parisi, Laura Marcolin [...]

Therapeutic Advances in Medical Oncology

Search results